EUVIMEDEUVIMED entdecken
Open Access

Paris saponin VII reverses resistance to PARP inhibitors by regulating ovarian cancer tumor angiogenesis and glycolysis through the RORα/ECM1/VEGFR2 signaling axis

Mengfei Wang, Chenyue Yuan, Zong Wu, Meng Xu, Ziqi Chen, Jialiang Yao, Zujun Que, Jianhui Tian, Elaine Lai-Han Leung, Ziliang Wang

International Journal of Biological Sciences · 2024 · 20 (7) · 2454-2475

DOI: 10.7150/ijbs.91861 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Biological Sciences, 2024. Verfasst von Mengfei Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Institute, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Vascular Endothelial Growth Factor Receptor-2, Saponins, Signal Transduction. Die Arbeit wurde bisher 25-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsVascular Endothelial Growth Factor Receptor-2SaponinsSignal TransductionGlycolysisNeovascularization, PathologicFemaleHumansCell Line, TumorDrug Resistance, NeoplasmPoly(ADP-ribose) Polymerase InhibitorsAnimalsMice, NudeMiceAngiogenesisDiosgenin

Stichwörter der Autor:innen

ECM1PARPi resistanceParis saponin VIIRORαVEGFR2angiogenesisglycolysisovarian cancer.

Substanzen

Vascular Endothelial Growth Factor Receptor-2SaponinsPoly(ADP-ribose) Polymerase Inhibitorsformosanin CDiosgenin

Autor:innen und Institutionen

  • Cancer Institute, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • Department of Oncology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • Cancer Center, Faculty of Health Sciences; MOE Frontiers Science Center for Precision Oncology, University of Macau, Macau (SAR), China.

Zitieren

APA

Wang, M., Yuan, C., Wu, Z., Xu, M., Chen, Z., Yao, J., Que, Z., Tian, J., Leung, E. L., & Wang, Z. (2024). Paris saponin VII reverses resistance to PARP inhibitors by regulating ovarian cancer tumor angiogenesis and glycolysis through the RORα/ECM1/VEGFR2 signaling axis. International Journal of Biological Sciences, 20(7), 2454-2475. https://doi.org/10.7150/ijbs.91861

Vancouver

Wang M, Yuan C, Wu Z, Xu M, Chen Z, Yao J, et al. Paris saponin VII reverses resistance to PARP inhibitors by regulating ovarian cancer tumor angiogenesis and glycolysis through the RORα/ECM1/VEGFR2 signaling axis. International Journal of Biological Sciences. 2024;20(7):2454-2475. doi:10.7150/ijbs.91861

BibTeX
@article{Wang2024,
  author = {Wang, Mengfei and Yuan, Chenyue and Wu, Zong and Xu, Meng and Chen, Ziqi and Yao, Jialiang and Que, Zujun and Tian, Jianhui and Leung, Elaine Lai-Han and Wang, Ziliang},
  title = {Paris saponin VII reverses resistance to PARP inhibitors by regulating ovarian cancer tumor angiogenesis and glycolysis through the RORα/ECM1/VEGFR2 signaling axis},
  journal = {International Journal of Biological Sciences},
  year = {2024},
  volume = {20},
  number = {7},
  pages = {2454--2475},
  doi = {10.7150/ijbs.91861}
}
Kostenlos starten →